New COVID-19 Travel Testing Order Set to Go into Effect Jan. 26
Summary of new Centers for Disease Control and Prevention (CDC) order affecting COVID-19 testing for all passengers from foreign countries.
COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration
Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.
Summary of new Centers for Disease Control and Prevention (CDC) order affecting COVID-19 testing for all passengers from foreign countries.
Curative SARS-Cov-2 diagnosis test providing high number of false negatives, FDA warns.
A new SARS-CoV-2 variant, B.1.1.7, was identified late last year in the UK, prompting the FDA to monitor existing tests, such as TaqPath, Linea, and Accula.
US Centers for Disease Control and Prevention orders airlines to verify and confirm documentation for COVID-19 negative testing for certain travelers.
Six questions pertaining to the US Food and Drug Administration’s updated medical Device Shortage List, and the primary testing supplies that were added.
“Through the FDA’s open and transparent scientific review process, …” : FDA Commissioner Stephen M. Hahn, MD, about the second EUA to cover a COVID-19 vaccine.
Summary of new Centers for Disease Control and Prevention (CDC) order affecting COVID-19 testing for all passengers from foreign countries.
Curative SARS-Cov-2 diagnosis test providing high number of false negatives, FDA warns.
A new SARS-CoV-2 variant, B.1.1.7, was identified late last year in the UK, prompting the FDA to monitor existing tests, such as TaqPath, Linea, and Accula.
US Centers for Disease Control and Prevention orders airlines to verify and confirm documentation for COVID-19 negative testing for certain travelers.
Six questions pertaining to the US Food and Drug Administration’s updated medical Device Shortage List, and the primary testing supplies that were added.
“Through the FDA’s open and transparent scientific review process, …” : FDA Commissioner Stephen M. Hahn, MD, about the second EUA to cover a COVID-19 vaccine.